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Figure 1. Case 1. A) Diffuse hyperpigmentation studded by 
hypopigmented macules over back. B) Sparing of dorsa of hands. C) 
Histopathology. Mild acanthosis, homogenous eosinophilic globular 
deposits in the papillary dermis (arrow) and melanophages in the 
upper dermis. H&E, 400×. D) Purple globules of amyloid in the 
papillary dermis. Crystal violet, 400×. 
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Introduction 
Primary cutaneous amyloidosis is the deposition of 
amyloid in the skin with no systemic involvement. 
Amyloidosis cutis dyschromica (ACD) is a rare 
subtype of primary cutaneous amyloidosis, which is 
characterized by dyspigmentation including diffuse 
asymptomatic or mildly pruritic hyperpigmentation 
and macular hypopigmentation. Histology 
examination shows papillary dermal amyloid 
deposition in pathologic examination [1]. About 50 
cases have been reported; however, the rising 
number of reported cases in recent years [1-5] may 
indicate that ACD is an under-recognized or under-
reported disease. About three-fourths of the 
reported cases are familial and the others are 
sporadic. Most of the reported cases (63%) are from 
Asia or South-East Asia [1]. Searching PubMed and 
Google Scholar, we found only one case of ACD 
reported from Iran [2]. Herein, we report three cases 
of familial ACD from Iran, one of whom is Afghani. 
Case Synopsis: 
Case 1 
The first case was a 20-year-old Afghani woman 
who presented to our dermatology clinic with 
Abstract 
Amyloidosis cutis dyschromica (ACD) is a rare 
pigmentary disorder with about 50 cases having 
been reported in the English literature. Only one 
case of ACD has been reported from Iran. We 
present three patients who presented with 
generalized hyper- and hypopigmented patches, 
sparing face, hands, and feet in all three cases. The 
presence of amorphous eosinophilic deposits in the 
papillary dermis confirmed the diagnosis of ACD; 
the deposits were stained by crystal violet in the 
histopathological examination of the lesions. In all 
three cases, similar lesions were present in some of 
the family members. ACD should be considered in 
the differential diagnosis of diffuse hyperpigmentation 
studded with hypopigmentation, especially when 
beginning in childhood. 
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Figure 2. Case 2. A) Diffuse hyperpigmentation and hypopigmented 
macules over trunk. B) Similar lesions on upper extremity sparing 
hand. C) Histopathology. Purple amyloid deposits in the papillary 
dermis. Crystal violet, 400×. D) Homogenous eosinophilic globules 
(arrow) and melanophages in the papillary dermis. H&E, 400×. 
dyspigmentation on her trunk and extremities. The 
skin lesions were not pruritic and they first started at 
6 years of age. She had no relevant past medical 
history and was taking no regular medications. Two 
of her paternal aunts and cousins had similar 
lesions. Her parents were consanguineous. 
Dermatological clinical examination revealed 
diffuse mottled hyper and hypopigmented macules 
of the trunk and extremities (Figure 1A). The dorsal 
aspect of the hands and feet, ventral surface of 
forearms, and face were spared (Figure 1B). No 
atrophy, telangiectasia, or erythema was noted. The 
patient’s hair, nails, mucous membranes, palms, and 
soles were normal. There was no systemic finding. 
Laboratory tests such as CBC, blood sugar, lipid 
profile, and liver function tests were normal. 
Histopathological evaluation of the skin biopsy 
specimen from hyper/hypopigmented areas 
indicated mild acanthosis and homogenous 
eosinophilic globular deposits in the papillary 
dermis, which were also remarkable in scanning 
microscopy. In addition, there was pigment 
incontinence and a mild perivascular infiltrate in the 
superficial dermis (Figure 1C). Positive staining with 
crystal violet confirmed the nature of globular 
dermal deposits for the diagnosis of amyloidosis 
(Figure 1D). Thus, clinicopathologic diagnosis of 
ACD was made and phototherapy was started. The 
lesions were still present following 100 sessions of 
narrow-band UVB twice weekly. Topical treatment 
was not helpful with combination of corticosteroid 
and tretinoin. Acitretin was not considered because 
of her age and poor compliance with long-term 
contraception. 
Case 2 
The second case was a 39-year-old Iranian woman 
who presented to our outpatient dermatology clinic 
with non-pruritic hyper/hypopigmented macules 
on her trunk and extremities. The skin lesions first 
appeared when she was 5 years old and were 
located on her upper and lower extremities; 
subsequently spread to her trunk was noted. The 
patient had reported that four of her 10 siblings 
(two sisters and two brothers) had similar lesions. 
The patient had no relevant past medical history 
except cleft lip and palate, which was treated 
surgically. She was taking no regular medications. 
Dermatological clinical examination showed diffuse 
hyper/hypopigmented macules of the trunk and 
extremities (Figure 2A). The dorsal aspect of the 
hands, face, and medial aspect of the forearm were 
spared as in our first case (Figure 2B). The patient’s 
hair, nails, mucous membranes, palms and soles 
were normal. 
Histopathological evaluation of the skin biopsy 
revealed intact epidermis with papillary dermis 
expansion with aggregates of homogenous hyaline 
bodies and pigment incontinence in the papillary 
dermis (Figure 2C). Crystal violet stain was positive 
for amyloid (Figure 2D). Considering the diagnosis 
of ACD, treatment with a combination of 
corticosteroid and tretinoin creams was 
commenced, but was not helpful. Topical 
application of 50% dimethyl sulfoxide (DMSO) 
resulted in irritation of the skin and did not 
ameliorate the lesions. She did not use  
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Figure 3. Case 3. A) Mild hyperpigmentation and superimposed 
guttate hypopigmented macules over the chest with relative 
sparing of face and neck. B) Histopathology. Homogenous pink 
deposits in the papillary dermis (Arrow). H&E, 400×. C) Purple 
globules of amyloid in the papillary dermis. Crystal violet, 400×.  
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contraception; so, acitretin was not a proper 
therapeutic option. 
Case 3 
A 32-year-old Iranian woman was referred to our 
outpatient dermatology clinic with 
dyspigmentation involving neck, trunk, and 
extremities. The problem was first noticed in 
childhood; however, she did not remember the 
exact age. Two brothers, two sisters, and two 
paternal uncles also had the same dyspigmentation. 
The parents were consanguineous. She had no 
history of any internal disease. 
Dermatological examination showed diffuse 
hyperpigmentation studded with hypopigmented 
macules, which involved all the body except for 
face, dorsum of hands and feet, and palms and soles 
(Figure 3A). Histopathological examination of the 
skin biopsy showed hyaline homogenous deposits 
in the papillary dermis, which were crystal violet-
positive (Figure 3C, D). She missed follow up; 
therefore, no treatment was started. 
Case Discussion 
Amyloidosis cutis dyschromica is a rarely reported 
subtype of primary cutaneous amyloidosis in Iran 
[2]. Amyloidosis cutis dyschromica has been most 
commonly reported in Asian and South-East Asian 
ethnic groups and it has been less frequently 
reported in the countries in our regional area of 
Turkey, Pakistan, and Saudi Arabia [6-8]. The first 
case in the present report is an Afghani woman, a 
related ethnicity. The other two patients were 
Iranian. ACD usually presents as diffuse 
hyperpigmentation gradually studded with 
hypopigmented macules. The lesions usually 
appear initially on the trunk and then progress to 
the extremities [1]. However, some patients report 
the first lesions on the extremities [3]. Both of these 
presentations were reported in our patients. 
Although ACD is usually asymptomatic in 
opposition to the other subtypes of primary 
cutaneous amyloidosis, pruritus is reported in 19% 
of cases [1]. 
Although most of the reported cases are familial, 
sporadic cases apparently unrelated to geneology 
have been reported. Consanguinity of the parents is 
not a ubiquitous feature [3, 8]. The mean age of 
diagnosis is 30 years and the mean age of onset of 
ACD in the familial cases is 6 years (lower than the 
sporadic cases), [1]. This time lag in diagnosis is 
significant and suggests a need for more awareness 
of the condition.   
Histological findings of the ACD lesions include 
homogenous eosinophilic deposits in the papillary 
dermis and superficial reticular dermis with a few 
melanophages. Special stains for amyloidosis such 
as Congo red, crystal violet, and thioflavine T usually 
highlight the amyloid deposits. Immuno-
histochemistry investigation shows positivity of 
cytokeratin markers (AE1/AE3, CK5/6, and 
CK34βE12) in the amyloid globules. Amyloid is seen 
as non-branching hollow thin fibrils under electron 
microscopy [7, 8]. 
No clue of systemic amyloidosis was detected in the 
reported cases of ACD, which indicates that 
systemic work up is not necessary [1]. Some 
associated diseases with ACD include morphea and 
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atypical Parkinsonism [7, 9]. One of the cases, which 
has been presented in the present article, had 
surgically repaired cleft lip and palate. One of the 
significant findings in the reported cases of ACD is 
relative sparing of face, hands, and feet. This was 
true of all three cases documented in this case 
report. Involvement of the face is reported in only 
20% of cases [1]. Actually, considering the sparing of 
sun-exposed areas in the majority of the reported 
cases, the possibility of a role for impaired DNA 
repair after exposure to UVB rays is in question as 
the pathogenesis of ACD [10]. The prevalence of 
ACD in some ethnic groups and familial cases 
suggests genetic factors as the cause of ACD. Some 
authors have suggested autosomal dominance with 
incomplete penetrance as the mode of inheritance 
[1]. However, it has been shown that a loss-of-
function mutation in glycoprotein non-metastatic 
gene B (GPNMB) was the cause of autosomal 
recessive ACD in 5 Taiwanese families [11]. 
Amyloidosis cutis dyschromica has been treated 
with various topical and systemic medications. 
Topical treatment has not been successful with 
corticosteroids, urea 10%, and tazarotene in reports. 
[1, 6]. Oral antioxidants (vitamins E and C) did not 
result in significant improvement [4]. Seven of the 8 
patients who were treated with acitretin have been 
reported to be improved [1]. Treatments with 
topical corticosteroid, retinoids, DMSO, and narrow-
band UVB phototherapy were disappointing in our 
patients. 
 
Conclusion 
In summary, ACD should be considered in any 
patient especially in the pediatric group who 
presents with dyspigmentation, and obtaining a 
thorough history including family history is 
necessary. Although no specific preventive or 
therapeutic measures have been successful for ACD 
yet, early histopathological examination of the 
biopsy specimen and complementary assessments 
with amyloid special stains and/or 
immunohistochemical studies will prevent 
unnecessary extensive investigations. The rarity of 
the disease makes it difficult to assess the 
therapeutic efficacy of treatments. 
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